ERBB2 and breast cancer: In the 19 cases with breast cancer metastases, the estrogen-receptor (ER) was conclusively analyzed in 14/14 cases (100%), the progesteron-receptor in 7/7 cases (100%), and Her2/neu in 10/11 cases (91%).